Literature DB >> 4181548

Alterations in immune responses by attenuated Venezuelan equine encephalitis vaccine. I. Adjuvant effect of VEE virus infection in guinea pigs.

C P Craig, S L Reynolds, J W Airhart, E V Staab.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4181548

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

1.  Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles.

Authors:  Daniel R Tonkin; Alan Whitmore; Robert E Johnston; Mario Barro
Journal:  Vaccine       Date:  2012-04-21       Impact factor: 3.641

2.  Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen.

Authors:  Joseph M Thompson; Alan C Whitmore; Herman F Staats; Robert E Johnston
Journal:  Vaccine       Date:  2008-06-09       Impact factor: 3.641

3.  Studies of viral virulence. I. Growth and histopathology of virulent and attenuated strains of Venezuelan encephalitis virus in hamsters.

Authors:  F J Austin; W F Scherer
Journal:  Am J Pathol       Date:  1971-02       Impact factor: 4.307

4.  Immune reactivity of Visna virus-inoculated mice.

Authors:  B Svennerholm; O Strannegård; E Lycke
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

5.  Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization.

Authors:  Daniel R Tonkin; Patricia Jorquera; Tracie Todd; Clayton W Beard; Robert E Johnston; Mario Barro
Journal:  Vaccine       Date:  2010-02-23       Impact factor: 3.641

6.  An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.

Authors:  Syed Muaz Khalil; Daniel R Tonkin; Andrew T Snead; Griffith D Parks; Robert E Johnston; Laura J White
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

7.  Persistent viral infections as models for research in virus chemotherapy.

Authors:  G Streissle
Journal:  Adv Virus Res       Date:  1981       Impact factor: 9.937
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.